10-Q Filing

BIO-TECHNE CORP CIK: 842023 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001558370-22-007844`
Period End Date	20220331
Filing Date	20220509
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	tmb-20220331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 95 Income Statement 100 Cash Flow Statement 87

Balance Sheet 95 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.52M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$199.09M	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$160.82M	USD	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$70.35M	USD	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$32.46M	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $1,522 and $1,229, respectively	`AccountsReceivableNetCurrent`	$145.38M	USD	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $1,522 and $1,229, respectively	`AccountsReceivableNetCurrent`	$202.09M	USD	Point-in-time
Inventories	`InventoryNet`	$116.75M	USD	Point-in-time
Inventories	`InventoryNet`	$128.28M	USD	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$31.56M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$16.92M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$593.11M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$510.61M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	39.26M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	38.96M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$207.91M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$218.40M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	38.96M	shares	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$63.45M	USD	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$73.83M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	39.26M	shares	Point-in-time
Goodwill	`Goodwill`	$843.07M	USD	Point-in-time
Goodwill	`Goodwill`	$827.62M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$615.97M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$551.34M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$11.57M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$45.98M	USD	Point-in-time
Total assets	`Assets`	$2.26B	USD	Point-in-time
Total assets	`Assets`	$2.30B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$30.86M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$29.38M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$55.64M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$51.29M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$15.28M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$20.00M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$23.11M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$19.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$5.34M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$9.79M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$11.60M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$11.86M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$4.00M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$3.89M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$3.08M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$166.84M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$152.28M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$93.12M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$99.30M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$246.51M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$328.83M	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$4.80M	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$25.40M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$67.62M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$56.35M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$12.77M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$24.46M	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 39,263,444 and 38,955,484, respectively	`CommonStockValue`	$393.00K	USD	Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 39,263,444 and 38,955,484, respectively	`CommonStockValue`	$390.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$636.32M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$534.41M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.13B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.09B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-57.29M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-55.15M	USD	Point-in-time
Total Bio-Techne's shareholders' equity	`StockholdersEquity`	$1.56B	USD	Point-in-time
Total Bio-Techne's shareholders' equity	`StockholdersEquity`	$1.71B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$8.26M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-1.05M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.70B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.38B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.44B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.71B	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$2.30B	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$2.26B	USD	Point-in-time

Income Statement 100 line items

Line Item	Tag	Value	Unit	Period
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$817.37M	USD	3 Qtrs
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$290.38M	USD	1 Quarter
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$672.00M	USD	3 Qtrs
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$243.55M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$261.23M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$88.92M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$75.28M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$215.10M	USD	3 Qtrs
Gross margin	`GrossProfit`	$201.46M	USD	1 Quarter
Gross margin	`GrossProfit`	$556.15M	USD	3 Qtrs
Gross margin	`GrossProfit`	$168.27M	USD	1 Quarter
Gross margin	`GrossProfit`	$456.91M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$276.14M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$238.31M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$82.60M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$89.27M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$21.74M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$17.05M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$49.88M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$63.99M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$340.13M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$111.01M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$99.65M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$288.19M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$90.45M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$216.02M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$168.71M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$68.63M	USD	1 Quarter
Other income (expense)	`NonoperatingIncomeExpense`	$6.32M	USD	3 Qtrs
Other income (expense)	`NonoperatingIncomeExpense`	$-23.27M	USD	1 Quarter
Other income (expense)	`NonoperatingIncomeExpense`	$-27.65M	USD	3 Qtrs
Other income (expense)	`NonoperatingIncomeExpense`	$-21.68M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$45.35M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$68.77M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$141.06M	USD	3 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$222.33M	USD	3 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$8.63M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$-48.00K	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$16.12M	USD	3 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$21.15M	USD	3 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$33.40M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$72.06M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$46.14M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$60.14M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$68.98M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$124.94M	USD	3 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$45.40M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$201.18M	USD	3 Qtrs
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-380.00K	USD	1 Quarter
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-595.00K	USD	1 Quarter
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-9.34M	USD	3 Qtrs
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-509.00K	USD	3 Qtrs
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$45.78M	USD	1 Quarter
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$125.45M	USD	3 Qtrs
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$60.74M	USD	1 Quarter
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$210.53M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-1.14M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-2.85M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$27.70M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-9.57M	USD	3 Qtrs
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$7.18M	USD	1 Quarter
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$5.49M	USD	3 Qtrs
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$1.29M	USD	1 Quarter
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$11.74M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$33.19M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$14.06M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$146.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$4.81M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-6.96M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$2.17M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$4.33M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$18.99M	USD	1 Quarter
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$26.00K	USD	3 Qtrs
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$-69.00K	USD	1 Quarter
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$-1.00K	USD	1 Quarter
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$14.00K	USD	3 Qtrs
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$4.33M	USD	1 Quarter
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$2.15M	USD	3 Qtrs
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$33.18M	USD	3 Qtrs
Other comprehensive income (loss) attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$215.00K	USD	1 Quarter
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$46.00M	USD	1 Quarter
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$158.63M	USD	3 Qtrs
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$212.67M	USD	3 Qtrs
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$65.07M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.24	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$5.36	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.18	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.55	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.11	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.48	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$5.12	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.12	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.86M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	39.23M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.69M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	39.27M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.97M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.30M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.68M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	41.07M	shares	3 Qtrs

Cash Flow Statement 87 line items

Line Item	Tag	Value	Unit	Period
Net earnings, including noncontrolling interest	`ProfitLoss`	$33.40M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$72.06M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$46.14M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$60.14M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$68.98M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$124.94M	USD	3 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$45.40M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$201.18M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$75.20M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$63.08M	USD	3 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$91.00K	USD	3 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$1.60M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-6.02M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$7.89M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$33.78M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$39.17M	USD	3 Qtrs
Contingent consideration payments - operating	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-3.30M	USD	3 Qtrs
Contingent consideration payments - operating	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-155.00K	USD	3 Qtrs
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$6.19M	USD	3 Qtrs
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$-20.60M	USD	3 Qtrs
Fair value adjustment on available for sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$-15.57M	USD	3 Qtrs
Fair value adjustment on available for sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$10.23M	USD	3 Qtrs
Asset impairment restructuring	`AssetImpairmentRestructuringCharge`	-	USD	3 Qtrs
Asset impairment restructuring	`AssetImpairmentRestructuringCharge`	$546.00K	USD	3 Qtrs
Eminence impairment	`GoodwillAndIntangibleAssetImpairment`	$18.71M	USD	3 Qtrs
Eminence impairment	`GoodwillAndIntangibleAssetImpairment`	-	USD	3 Qtrs
Leases, net	`NoncashPortionOfLeaseExpense`	$83.00K	USD	3 Qtrs
Leases, net	`NoncashPortionOfLeaseExpense`	$-974.00K	USD	3 Qtrs
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$-608.00K	USD	3 Qtrs
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$549.00K	USD	3 Qtrs
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$32.71M	USD	3 Qtrs
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$60.93M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$16.03M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$4.12M	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$3.58M	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-414.00K	USD	3 Qtrs
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$11.23M	USD	3 Qtrs
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$12.20M	USD	3 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$2.06M	USD	3 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$13.83M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$3.53M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-9.21M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$230.14M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$222.56M	USD	3 Qtrs
Proceeds from maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$66.38M	USD	3 Qtrs
Proceeds from maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$26.05M	USD	3 Qtrs
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$48.00M	USD	3 Qtrs
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$39.68M	USD	3 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$31.34M	USD	3 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$32.98M	USD	3 Qtrs
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$9.77M	USD	3 Qtrs
Investment in unconsolidated entity	`InvestmentInUnconsolidatedEntity`	$556.00K	USD	3 Qtrs
Investment of forward purchase contract	`PaymentsForProceedsFromOtherInvestingActivities`	$25.00M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-78.28M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-16.61M	USD	3 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$37.65M	USD	3 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$37.17M	USD	3 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$54.99M	USD	3 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$68.35M	USD	3 Qtrs
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$43.18M	USD	3 Qtrs
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$102.13M	USD	3 Qtrs
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	$90.00M	USD	3 Qtrs
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	-	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$172.38M	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$141.38M	USD	3 Qtrs
Contingent consideration payments - financing	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$700.00K	USD	3 Qtrs
Contingent consideration payments - financing	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	3 Qtrs
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$-22.62M	USD	3 Qtrs
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$-13.50M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-177.12M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-180.24M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-5.42M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$6.22M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$39.51M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-38.27M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$160.82M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$199.09M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$186.14M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$160.82M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$199.09M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$186.14M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$22.96M	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$17.96M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$8.52M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$10.73M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.